Assenagon Asset Management S.A. Catalyst Biosciences, Inc. Transaction History

Assenagon Asset Management S.A.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 25, 2022	SELL	$0.51 - $1.0 $261,447 - $512,643	-512,643 Closed	0 $0
Q4 2021 Feb 01, 2022	BUY	$0.91 - $4.16 $466,505 - $2.13 Million	512,643 New	512,643 $469,000
Q3 2020 Oct 07, 2020	SELL	$4.22 - $6.04 $638,743 - $914,220	-151,361 Closed	0 $0
Q2 2020 Jul 21, 2020	BUY	$3.76 - $8.01 $569,117 - $1.21 Million	151,361 New	151,361 $888,000
Q2 2019 Aug 12, 2019	SELL	$7.08 - $10.6 $2.04 Million - $3.06 Million	-288,600 Closed	0 $0
Q1 2019 Apr 26, 2019	BUY	$7.67 - $9.96 $641,986 - $833,661	83,701 Added 40.85%	288,600 $2.34 Million
Q4 2018 Jan 23, 2019	BUY	$6.59 - $11.28 $1.35 Million - $2.31 Million	204,899 New	204,899 $1.62 Million

215

Ticker CBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,477,100
Description
Catalyst Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on developing protease product candidates in the fields of hemostasis and complement regulation. The company's protease engineering platform creates improved or novel molecules to treat diseases that result from dysregulation of the complement system. It develops CB ...

Get notified when there are updates to the investment portfolio of Assenagon Asset Management S.A., based on Form 13F filings with the SEC.

Stay updated on Assenagon Asset Management S.A. with notifications on news.